Unleashing the Power of Partnerships

At Basepair, we believe in the strength of collaboration and the transformative potential that partnerships hold. We also believe partnership can take different forms. On the one hand we are dedicated to forging strategic alliances with leading organizations, researchers, and industry experts to achieve technology integration that will ultimately drive innovation and advance the field of genomics. In addition, we also recognize the power of co promotion and co marketing to help further the growth goals of partner organizations. That’s why we launched the Basepair Partner Program (BPP) that includes a multitude of benefits for member organizations, not least unlimited sample processing through the Basepair platform.

 

Featured Partners

Why Partner with Us?

Distributors & Resellers

Collaborative Network

By joining forces with Basepair, you become part of a vibrant and interconnected scientific community of over 5,000 subscribers. Our network of technology and scientific partners, researchers, and thought leaders fosters collaboration, knowledge exchange, and opportunities for joint projects and publications.

Customized Solutions

We understand that every partner has unique requirements. That’s why we work closely with our collaborators to develop tailored solutions that align with their specific goals and objectives. Our team of experts will collaborate with you to design and implement customized workflows, ensuring that our partnership delivers maximum value.

Cutting-edge Technology

Access our cutting edge algorithms and cloud technology built into our state-of-the-art bioinformatics platform, which enable efficient and accurate federated analysis of NGS data. By partnering with Basepair, you gain access to a modern tech stack and methodologies that will propel your research to new heights.

Bioinformatics Expertise

Leverage our expertise in next-generation sequencing (NGS) analysis & visualization to enhance your research capabilities and gain a competitive edge. With our deep understanding of genomic data analysis, we empower our partners to unlock new insights and accelerate scientific discoveries.

Unlock the Power of Basepair’s Partner Program Today

Discover the limitless potential of joining the BPP. Together we can revolutionize genomics research and drive breakthroughs that have a lasting impact on human health and well-being. Founding members receive the following benefits:

Cloud IT Infrastructure

Innovative Solutions

Unlimited Sample Processing for a Low, Flat, Annual Fee. Yes, you heard us correctly, no complicated throughput, user or consumption based model that does not scale cost effectively.

Customized Solutions

White labeling and bundling of analysis with the sale of another product or service such as kits, hardware or contract research. Why build your own bioinformatics platform or sign a co marketing agreement whit a third party software company when you can effectively have your own portal?

 

Cutting-edge Technology

Access to over 5,000 subscribers and to the platform across academic, industry and government organizations around the world.

Bioinformatics Expertise

A marketplace to showcase and monetize the value of in house built bioinformatics pipelines through a point & click graphical user interface to the broader scientific community

As a growing company we want to showcase the value of the Basepair platform and what better way to do that than through our partners. Therefore by joining the BPP we ask that you be comfortable helping us do this by developing a case study, delivering a scientific talk at a conference, or helping with a presentation on a future webinar to talk about your experience of collaborating with us.

Join us in our mission to unravel the mysteries of the genome and transform the future of precision medicine. Contact our partnership team today to explore how we can collaborate and achieve remarkable results together or alternatively check out some of our partnerships below.

Basepair partners with AWS to bring the benefits of point & click bioinformatics using the compute & storage resources in a client’s own AWS account. This federated approach to NGS analysis & interpretation not only enables enhanced security & data privacy and improved connectivity to other cloud resources being used, but also results in considerable cost savings.

As a member of the Amazon Partner Network with Qualified Software Partner status, organizations can be confident that the Basepair platform is built on AWS Well-Architected best practices related to aspects such as reliability, cost optimization and performance efficiency.

Basepair is available on AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on Amazon Web Services (AWS). This effectively makes it even easier to access point & click bioinformatics through a free trial at an affordable rate. Basepair is also featured on the associated Life Sciences Solutions Page alongside other industry leading organizations in their respective areas.

Basepair on AWS brings the following benefits to organizations looking to migrate, deploy, orchestrate and scale bioinformatics workflows in the cloud:

Web-Based: No Software To Install

Sign-up online in less than a minute, no software to install, manage and upgrade. No hardware required either. Your samples and results are available at your office, home or conference, 24-7.
Z

Easy To Use: Run Analyses in Minutes

Run complex workflows with just a few clicks. Most users take less than a minute of hands-on time to add a sample and run an analysis. Our workflows show all the steps of the analysis to help the users understand exactly how their data will be analyzed.

True Connected Cloud - Use Your own Cloud

Basepair is available in a multitude of cloud regions around the world to allow you to operate globally. Connect the platform to both your compute and storage resources in your own cloud account to achieve economies of scale with your cloud provider, or, for plug and play, use the multi-tenanted version which manages everything for you.

Interactive Publication Ready Reports

From heatmaps to volcano plots, interact with NGS data directly in the online report. Use filters and sliders to adjust your parameters, download your figures in high resolution, or export files for additional analysis.

Complete Genomics, a life sciences company based in San Jose, California, is a pioneering global leader in driving genomics forward with complete sequencing solutions that improve lives. Since its establishment in June 2005, the company has been at the forefront of research and development, specializing in the development and commercialization of DNA sequencing platforms for human genome sequencing and analysis. Complete Genomics takes pride in its ability to develop and manufacture a full spectrum of instruments, ranging from low to extra-high throughput genetic sequencers, accelerating scientific breakthroughs for researchers and scientists. The company’s innovative DNBSEQ sequencing technology and robust automation have made it a go-to choice for whole genome sequencing, transcriptome sequencing, and a wide range of other applications, catering to the diverse needs of labs and research facilities worldwide. By empowering customers and partners with the unlimited potential of genomic sequencing for healthcare and industrial applications, Complete Genomics is dedicated to improving overall human health and driving health innovations.

OnQ Software’s flagship product QLIMS is a modern, cloud-native Laboratory Information Management System built for scalability, automation and ease of use. It manages the full lab workflow, from sample tracking and inventory to instrument integration and regulatory compliance, without heavy IT overhead. 

Partnering with Basepair aligns perfectly with this mission. Basepair’s intuitive, web-based platform simplifies NGS (next-generation sequencing) data analysis and bioinformatics workflows, enabling researchers and lab teams to go from raw data to insight without deep coding expertise. Together, QLIMS and Basepair empower labs to streamline operations and scale genomics workflows with confidence, driving faster scientific discovery and higher throughput.

 

Nkarta is dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Their proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing their ability to search and destroy tumor cells. Throughout their development process, Nkarta scientists create increasing amounts of NGS data across multiple application areas that require analysis. But without a way for scientists to perform routine analysis independently, they were experiencing a significant bottleneck in analysis that delayed scientific insights. Basepair partnered with Nkarta to help execute on their vision of enabling every non-bioinformatician to become a data scientist by giving them tools and visualizations to be able to analyze their own data without always needing to work with a bioinformatician.

 

Nalagenetics is a leading precision medicine company in Southeast Asia, dedicated to integrating genomics into routine clinical practice through cost-effective and clinically actionable genetic testing. By combining assay development, bioinformatics, and clinical interpretation, Nalagenetics enables personalized healthcare at scale.

Partnering with Basepair supports this mission. Basepair’s cloud-based, no-code NGS analysis platform streamlines data processing and interpretation, making complex bioinformatics accessible to clinical and research teams. Together, Nalagenetics and Basepair are advancing personalized medicine by delivering faster, more accurate, and scalable genomic insights to healthcare providers across the region.

Scale Biosciences is a cutting-edge life sciences company specializing in innovative single-cell library preparation approaches. Their patented methods enable cost-effective single-cell analysis, allowing researchers to ask new questions in single-cell research. The company’s mission is to enable researchers across a broad range of fields to unlock complex biology and pave the way for groundbreaking scientific breakthroughs. Scale Biosciences’ technology offers scalable cell throughput, scalable sample indexing, highly efficient chemistries, and low library preparation costs. By focusing on single-cell analysis, Scale Biosciences aims to transform the field and contribute to the next generation of biomedical research breakthroughs.

IWAI Chem, is a prominent distributor of NGS and NGS data analysis services in Japan. Recognizing the complexity of bioinformatics tools and the challenges researchers face with command-line–based platforms, IWAI Chem is committed to bridging this gap by offering accessible, scalable solutions for life science organizations.

Partnering with Basepair aligns with this mission. Basepair’s intuitive, web-based platform simplifies NGS data analysis, enabling researchers regardless of coding expertise to derive meaningful insights from sequencing data. Together, IWAI Chem and Basepair aim to empower researchers with seamless access to powerful, no-code bioinformatics tools, accelerating scientific discovery and expanding NGS accessibility across Japan.

Scientist.com is the premier AI-driven research services marketplace that connects scientists, biotech firms and pharma organizations with thousands of pre-qualified suppliers worldwide to accelerate innovation and streamline R&D.
scientist.com

Partnering with Basepair aligns seamlessly with this mission. Basepair’s cloud-native, no-code NGS analysis platform extends Scientist.com’s value chain into the genomics workflow, making seamless transition from sample to insight possible. Together, Scientist.com and Basepair enable research teams to move from procurement to analysis in one elevated ecosystem, empowering life-science organizations to accelerate discovery, reduce operational friction and maximise ROI on sequencing investments.